Cellectar to participate in the ladenburg thalmann 2021 virtual healthcare conference

Florham park, n.j., july 08, 2021 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that james caruso, president and ceo, will present a company overview and be available for 1x1 meetings at the following upcoming conference:
CLRB Ratings Summary
CLRB Quant Ranking